📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma. (2021)

First Author: Hussein Z

Attributed to: The effect of AIP mutations on the apoptotic RET pathway in pituitary adenomas funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1530/edm-21-0003

PubMed Identifier: 34110302

Publication URI: http://europepmc.org/abstract/MED/34110302

Type: Journal Article/Review

Volume: 2021

Parent Publication: Endocrinology, diabetes & metabolism case reports

ISSN: 2052-0573